Clinical progression of opportunistic infections and their correlation with CD4 count in newly diagnosed HIV positive patients when attending tertiary care hospital

Vasanti C. Visawale; Shilpa S. Patil; Suvarna B. Landge

doi:10.18203/2320-6012.ijrms20261700

Authors

Vasanti C. Visawale Government Medical College, Ambernath, Maharashtra, India
Shilpa S. Patil Grant Government Medical College, Mumbai, Maharashtra, India
Suvarna B. Landge Kashibai Navale Medical college, Pune, Maharashtra, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261700

Keywords:

HIV, CD4 count, Opportunistic infection, Tuberculosis

Abstract

Background: HIV is a great threat faced by humanity in India. Opportunistic infections (OIs) arise due to progressive decline in CD4 count. HIV related OIs are the major causes of morbidity and mortality. The most prevalent OI reported in India is tuberculosis followed by candidiasis and diarrhoeal diseases. The study aimed to evaluate spectrum OIs in newly diagnosed HIV positive patients and their relation with CD4 count.

Methods: A prospective observational study was conducted over a period of 18 months from January 2021 to June 2022 at ART centre of a tertiary care hospital. All newly diagnosed HIV positive patients were clinically evaluated and monitored for absolute CD4 count by flow cytometer.

Results: A total of 117 newly diagnosed HIV patients were enrolled, of whom 100 patients completed two follow -up. Among these, 65% were males and 35% females. The mean CD4 cell count was 289.04 cells/mm³.OIs were observed in 57% of patients. Of these, at ART initiation,71.93% patients had OIs, while 24.56% and 3.51% developed during 1^st and 2^nd follow up respectively. Tuberculosis was found to be most prevalent infection among HIV patients. Of total OIs, 24.56% patients of pulmonary tuberculosis and 17.54% extrapulmonary tuberculosis, followed by Oral candidiasis (26.31%).

Conclusions: Tuberculosis was the most common OI in newly diagnosed HIV positive patients. OIs were more frequent in patients with lower CD4 counts. Early diagnosis, prompt initiation of treatment and periodic monitoring of CD4 count were key to manage HIV related OIs.

References

UNAIDS. The path that ends AIDS: UNAIDS global AIDS update 2023. Geneva: Joint United Nations Programme on HIV/AIDS. 2023. Available at: https://www.unaids.org/en/resources/documents/2023/global-aids-update-2023?. Accessed on 09 March 2026.

National AIDS Control Organisation (NACO), ICMR–National Institute for Research in Digital Health and Data Science (ICMR-NIRDHDS). India HIV estimates 2023: technical report. New Delhi: NACO, Ministry of Health and Family Welfare, Government of India. 2024. Available at: https://naco.gov.in/sites/default/files/HIV%20Estimation%202023%20Technical%20Report.pdf?. Accessed on 09 March 2026.

Seligmann M. Immunological features of human immunodeficiency virus disease. Baillieres Clin Haematol. 1990;3(1):37-63.

Ananthanarayan R, Paniker CKJ. Ananthanarayan and Paniker’s textbook of microbiology. 9th ed. Hyderabad: Orient Longman. 2005.

Palella FJ, Baker RK, Moorman AC. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr. 2006;43(1):27-34.

Justiz Vaillant AA, Naik R. HIV-1–associated opportunistic infections. StatPearls. Treasure Island (FL): StatPearls Publishing. 2026.

Ford N, Meintjes G, Vitoria M, Greene G, Chiller T. The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017;12(2):123-8.

Gautam H, Bhalla P, Saini S, Dewan R. Correlation between baseline CD4+ T-lymphocyte count and plasma viral load in AIDS patients and their early clinical and immunological response to HAART: a preliminary study. Indian J Med Microbiol. 2008;26(3):256-8.

National AIDS Control Organization, Ministry of Health and Family Welfare, Government of India. National technical guidelines on antiretroviral treatment. New Delhi: NACO. 2018. Available at: https://naco.gov.in/sites/default/files/NACO%20.%20National%20Technical%20Guidelines%20on%20ART_October%202018%20%281%29.pdf. Accessed on 09 March 2026.

Konrad S, Skinner S, Kazadi GB, Gartner K, Lim HJ. HIV disease progression to CD4 count <200 cells/μL and death in Saskatoon, Saskatchewan. Can J Infect Dis Med Microbiol. 2013;24(2):97-101.

Advani M, Chandwani J, Rastogi VL, Meena CK. Assessment of CD4 cell count and viral load test in HIV-infected adults. Int J Sci Res. 2020;9(11).

Chadha S, Bhalla P, Jha AK, Gautam H, Saini S, Anuradha S, et al. Disease progression and antiretroviral therapy in newly seropositive HIV subjects in a tertiary care hospital in North India. J Infect Dev Ctries. 2013;7(2):110-5.

Duong T, Jourdain G, Ngo-Giang-Huong N, Le Cœur S, Kantipong P, Buranabanjasatean S, et al. Laboratory and clinical predictors of disease progression following initiation of combination therapy in HIV-infected adults in Thailand. PLoS One. 2012;7(8):e43375.

Langford SE, Ananworanich J, Cooper DA. Predictors of disease progression in HIV infection: a review. AIDS Res Ther. 2007;4:11.

Haokip P, Singh HR, Laldinmawii G, Marak EK, Roy A. Quantification of human immunodeficiency virus-1 viral load and its correlation with CD4 cell count in antiretroviral therapy-naïve patients attending Regional Institute of Medical Sciences Hospital. Imphal J Med Soc. 2018;32:98-102.

Kassie A. Predictors of CD4+ count changes in HIV-infected patients receiving antiretroviral therapy. Res Sq. 2022.

Shoko C, Chikobvu D. A superiority of viral load over CD4 cell count when predicting mortality in HIV patients on therapy. BMC Infect Dis. 2019;19(1):169.

Saha K, Firdaus R, Santra P, Pal J, Roy A, Bhattacharya MK, et al. Recent pattern of co-infection amongst HIV seropositive individuals in a tertiary care hospital, Kolkata. Virol J. 2011;8:116.

Bayeh A, Fisseha W, Tsehaye T, Atnaf A, Mohammed Y. ART-naive HIV-infected patients at Feleg-Hiwot Referral Hospital, Northwest Ethiopia. Ethiop J Health Dev. 2010;24(1):3-8.

Shahapur PR, Bidri RC. Recent trends in the spectrum of opportunistic infections in human immunodeficiency virus infected individuals on antiretroviral therapy in South India. J Nat Sci Biol Med. 2014;5(2):392-6.

Low A, Gavriilidis G, Larke N, B-Lajoie MR, Drouin O, Stover J, et al. Incidence of opportunistic infections and the impact of antiretroviral therapy among HIV-infected adults in low- and middle-income countries: a systematic review and meta-analysis. Clin Infect Dis. 2016;62(12):1595-603.